McKesson Q2 earnings beat estimates on specialty growth, raises outlook
Specialty distribution profits are carrying the largest US drug distributors amid pressure on core operations.
Read at TradingView →Full coverage · 7 outlets
- TradingView · lead
- Pharmaceutical CommerceBig Three Distributors Lean on Specialty for Profit Growth
- The Globe and MailMCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
- Yahoo FinanceWill MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?
- BigGo Finance[McKesson Q2 2027 Earnings Call] McKesson Raises FY2027 EPS Guidance to $45.60-$46.40, Beats on 8% Revenue Growth and 26% GLP-1 Surge
- ReutersMcKesson raises annual profit forecast on robust demand for specialty drugs
- YahooMCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised